Visualizar por autor "León Serrano, Javier"

A novel role of MNT as a negative regulator of REL and the NF-kB pathway

Liaño Pons, Judit; Lafita Navarro, María Carmen; García Gaipo, Lorena

; Colomer, Carlota; Rodríguez, Javier; Kriesgheim, Alex von; Hurlin, Peter J; Ourique Da Silva, Fabiana; Delgado Villar, María Dolores

; Bigas, Anna; Espinosa, ML; León Serrano, Javier

(Springer Nature, 2021)

Análisis de la expresión de genes de la red MYC-MNT en células de linfoma y leucemia

Martínez-Conde Toca, Marta (2024-06-05)

CD21/CR2 as a possible Myc target gene in hematopoietic cell lines

Molina Hoyo, Ester (2014-08-12)

CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia

Guerra, Borja; Martín Rodríguez, Patricia; Díaz Chico, Juan Carlos; McNaughton-Smith, Grant; Jiménez Alonso, Sandra; Hueso Falcón, Idaira; Montero, Juan Carlos; Blanco Lang, Raquel; León Serrano, Javier

; Rodríguez González, Germán; Estévez Braun, Ana; Pandiella, Atanasio; Díaz Chico, Bonifacio Nicolás; Fernández Pérez, Leandro (Impact Journals, 2017)

CTCF regulates growth and erythroid differentiation of human myeloid leukemia cells

Torrano Moya, Verónica; Chernukhin, Igor; Docquier, France; D'Arcy, Vivien; León Serrano, Javier

; Klenova, Elena; Delgado Villar, María Dolores

(American Society for Biochemistry and Molecular Biology Inc., 2005)

Funciones de p21 en la regulación génica y en la apoptosis por inhibidores de tirosina-quinasa. Estudio en modelos de cáncer colorectal y leucemia mieloide

Ferrándiz Díaz, Nuria (2007-10-26)

High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle

Caraballo Otero, Juan Manuel; Acosta Cobacho, Juan Carlos; Cortés Vázquez, Miguel Ángel; Albajar Molera, Marta; Gómez Casares, María Teresa; Batllé López, Ana

; Cuadrado, María Ángeles; Onaindia Pérez, Arantza; Bretones Sánchez, Gabriel; Llorca Díaz, Francisco Javier

; Piris Pinilla, Miguel Ángel

; Colomer Pujol, Dolors; León Serrano, Javier

(Impact Journals, 2014-07-15)

JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia

Aranda-Tavío, Haidée; Recio, Carlota; Martín-Acosta, Pedro; Guerra-Rodríguez, Miguel; Brito-Casillas, Yeray; Blanco Fernández, Rosa

; Junco Ruisánchez, Vanessa

; León Serrano, Javier

; Montero, Juan Carlos; Gandullo-Sánchez, Lucía; McNaughton-Smith, Grant; Zapata, Juan Manuel; Pandiella, Atanasio; Amesty, Ángel; Estévez-Braun, Ana; Fernández-Pérez, Leandro; Guerra, Borja (Editions Scientifiques Elsevier, 2021-12)

Mecanismos epigenéticos en la diferenciación eritroide y linfoide : el regulador transcripcional CTCF y fármacos epigenéticos

García Gaipo, Lorena

(2019-12-13)

Mecanismos moleculares responsables de la transformación en la leucemia mieloide crónica

León Serrano, Javier

; Albajar, M. (Ferrata Storti Foundation, 2010)

(Impact Journals, 2016)

Myc and cell cycle control

Bretones Sánchez, Gabriel; Delgado Villar, María Dolores

; León Serrano, Javier

(Elsevier, 2015)

MYC as therapeutic target in leukemia and lymphoma

Cortiguera Ruiz, María Gabriela; Batllé López, Ana

; Albajar Molera, Marta; Delgado Villar, María Dolores

; León Serrano, Javier

(Dove Medical Press, 2015-07-22)

MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells

Molina Hoyo, Ester; García Gutiérrez, Lucía; Junco Ruisánchez, Vanessa

; Pérez-Olivares, Mercedes; Yébenes, Virgina G. de; Blanco Fernández, Rosa

; Quevedo Palacio, Laura

; Acosta Cobacho, Juan Carlos; Marín, Ana V.; Ulgiati, Daniela; Merino Pérez, Ramón

; Delgado Villar, María Dolores

; Varela Egocheaga, Ignacio

; Regueiro, José R.; Moreno de Alborán, Ignacio; Ramiro, Almudena R.; León Serrano, Javier

(Basingstoke : Nature Publishing Group, 2023)

MYC oncogene contributions to release of cell cycle brakes

García Gutiérrez, Lucía; Delgado Villar, María Dolores

; León Serrano, Javier

(MDPI, 2019)

Myc oncoprotein role in the regulation of transcription, differentiation and senescence

Quintanilla Cavia, Andrea (2013-11-13)

Myc Stimulates Cell Cycle Progression Through the Activation of Cdk1 and Phosphorylation of p27

García Gutiérrez, Lucía; Bretones Sánchez, Gabriel; MOLINA HOYO, ESTER; Arechaga Iturregui, Ignacio María

; Symonds, Catherine; Acosta Cobacho, Juan Carlos; Blanco Fernández, Rosa

; Fernández, Adrián; Alonso, Leticia; Sicinski, Piotr; Barbacid, Mariano; Santamaría, David; León Serrano, Javier

(Nature Publishing Group, 2019)

Myc-p27 expression and interactions in chronic lymphocytic leukemia and in myeloid cells differentiation

Caraballo Otero, Juan Manuel (2013-05-31)

Visualizar por autor "León Serrano, Javier"

A novel role of MNT as a negative regulator of REL and the NF-kB pathway

Análisis de la expresión de genes de la red MYC-MNT en células de linfoma y leucemia

CD21/CR2 as a possible Myc target gene in hematopoietic cell lines

CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia

CTCF regulates growth and erythroid differentiation of human myeloid leukemia cells

Funciones de p21 en la regulación génica y en la apoptosis por inhibidores de tirosina-quinasa. Estudio en modelos de cáncer colorectal y leucemia mieloide

High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle

JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia

Mecanismos epigenéticos en la diferenciación eritroide y linfoide : el regulador transcripcional CTCF y fármacos epigenéticos

Mecanismos moleculares responsables de la transformación en la leucemia mieloide crónica

Metabolic stress and Myc expression

MNT and CCDC6 in cutaneous T cell lymphoma cells

MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis

Myc and cell cycle control

MYC as therapeutic target in leukemia and lymphoma

MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells

MYC oncogene contributions to release of cell cycle brakes

Myc oncoprotein role in the regulation of transcription, differentiation and senescence

Myc Stimulates Cell Cycle Progression Through the Activation of Cdk1 and Phosphorylation of p27

Myc-p27 expression and interactions in chronic lymphocytic leukemia and in myeloid cells differentiation

Listar

Mi cuenta

Sobre UCrea

Piensa en abierto

Compartir

Visualizar por autor "León Serrano, Javier"

A novel role of MNT as a negative regulator of REL and the NF-kB pathway ﻿

Análisis de la expresión de genes de la red MYC-MNT en células de linfoma y leucemia ﻿

CD21/CR2 as a possible Myc target gene in hematopoietic cell lines ﻿

CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia ﻿

CTCF regulates growth and erythroid differentiation of human myeloid leukemia cells ﻿

Funciones de p21 en la regulación génica y en la apoptosis por inhibidores de tirosina-quinasa. Estudio en modelos de cáncer colorectal y leucemia mieloide ﻿

High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle ﻿

JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia ﻿

Mecanismos epigenéticos en la diferenciación eritroide y linfoide : el regulador transcripcional CTCF y fármacos epigenéticos ﻿

Mecanismos moleculares responsables de la transformación en la leucemia mieloide crónica ﻿

Metabolic stress and Myc expression ﻿

MNT and CCDC6 in cutaneous T cell lymphoma cells ﻿

MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis ﻿

Myc and cell cycle control ﻿

MYC as therapeutic target in leukemia and lymphoma ﻿

MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells ﻿

MYC oncogene contributions to release of cell cycle brakes ﻿

Myc oncoprotein role in the regulation of transcription, differentiation and senescence ﻿

Myc Stimulates Cell Cycle Progression Through the Activation of Cdk1 and Phosphorylation of p27 ﻿

Myc-p27 expression and interactions in chronic lymphocytic leukemia and in myeloid cells differentiation ﻿

A novel role of MNT as a negative regulator of REL and the NF-kB pathway

Análisis de la expresión de genes de la red MYC-MNT en células de linfoma y leucemia

CD21/CR2 as a possible Myc target gene in hematopoietic cell lines

CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia

CTCF regulates growth and erythroid differentiation of human myeloid leukemia cells

Funciones de p21 en la regulación génica y en la apoptosis por inhibidores de tirosina-quinasa. Estudio en modelos de cáncer colorectal y leucemia mieloide

High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle

JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia

Mecanismos epigenéticos en la diferenciación eritroide y linfoide : el regulador transcripcional CTCF y fármacos epigenéticos

Mecanismos moleculares responsables de la transformación en la leucemia mieloide crónica

Metabolic stress and Myc expression

MNT and CCDC6 in cutaneous T cell lymphoma cells

MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis

Myc and cell cycle control

MYC as therapeutic target in leukemia and lymphoma

MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells

MYC oncogene contributions to release of cell cycle brakes

Myc oncoprotein role in the regulation of transcription, differentiation and senescence

Myc Stimulates Cell Cycle Progression Through the Activation of Cdk1 and Phosphorylation of p27

Myc-p27 expression and interactions in chronic lymphocytic leukemia and in myeloid cells differentiation